Overview of morphological changes in Parkinson's disease.
D000110:Acetylcholinesterase / Q000378:metabolism; D000544:Alzheimer Disease / Q000473:pathology; D001921:Brain / Q000473:pathology*; D002540:Cerebral Cortex / Q000473:pathology; D002544:Cerebral Infarction / Q000473:pathology; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D002799:Cholinergic Fibers / Q000473:pathology; D003704:Dementia / Q000473:pathology; D006624:Hippocampus / Q000473:pathology; D006801:Humans; D009454:Neurofibrils / Q000648:ultrastructure; D009474:Neurons / Q000648:ultrastructure; D009479:Neuropeptides / Q000378:metabolism; D010300:Parkinson Disease / Q000473:pathology*; D010301:Parkinson Disease, Postencephalitic / Q000473:pathology
D009479:Neuropeptides; D002795:Choline O-Acetyltransferase; D000110:Acetylcholinesterase